提供学术论文选刊润色服务
医学
医学
Paper Review Records
全部论文审稿周期
19 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
153
天
A Noncanonical MET Exon 14 Splice‐Site Variant in Pulmonary Sarcomatoid Carcinoma With Response to Capmatinib
作者Hyung‐Joo Oh; Yoo‐Duk Choi; Yoon‐La Choi; Ha‐Young Park; Joon‐Young Yoon; Jang‐Hyeon Kim; Jung‐Hwan Lim; Cheol‐Kyu Park; In‐Jae Oh; Young‐Chul Kim
作者单位1. Division of Pulmonology, Department of Internal Medicine Chonnam National University Medical School Gwangju South Korea; 2. Lung Cancer Center Chonnam National University Hwasun Hospital Gwangju South Korea; 3. Department of Pathology Chonnam National University Medical School Gwangju South Korea; 4. Department of Pathology & Translational Genomics Samsung Medical Center, Sungkyungwan University School of Medicine Seoul South Korea
82
天
Overall Survival With Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2 ‐Positive Metastatic Breast Cancer: A Single‐Center Pooled Analysis
作者Jialin Lin; Qiao Li; Pin Zhang; Ying Fan; Ruigang Cai; Yang Luo; Bo Lan; Shanshan Chen; Jiani Wang; Hongnan Mo; Fei Ma; Jiayu Wang; Binghe Xu
作者单位1. Department of Medical Oncology National Cancer Center, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China; 2. Beijing Key Laboratory of Innovative Drug R&D and Translational Research for Breast Cancer Beijing China
165
天
Insights Into Genomic Drivers, Transcriptomic Heterogeneity, and Therapeutic Vulnerabilities From Novel Mesothelioma Cell Lines
作者Yani Wu; Fang Cao; Jiayin Dai; Zhenli Yang; Yanli Zhu; Dongmei Lin; Xiaocui Bian; Yuqin Liu
作者单位1. Department of Pathology, Cell Resource Center, Institute of Basic Medical Sciences and School of Basic Medicine Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China; 2. Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education) Peking University Cancer Hospital and Institute Beijing China
194
天
Advanced Thymoma and Advanced Thymic Carcinoma Treatment Practices in 2018–2022: A Nationwide Analysis in Japan
作者Junichi Ishigaki; Ryoko Rikitake; Hidenori Kage; Takahiro Higashi
作者单位1. Department of Public Health and Health Policy, Graduate School of Medicine The University of Tokyo Tokyo Japan; 2. Department of Respiratory Medicine, Graduate School of Medicine The University of Tokyo Tokyo Japan; 3. Rare Cancer Center National Cancer Center Hospital Tokyo Japan; 4. Division of Health Services Research Institute for Cancer Control, National Cancer Center Tokyo Japan
137
天
ctDNA Detection of Polyclonal KRAS Resistance in Adagrasib‐Treated NSCLC
作者Marion Caumeil; Julie A. Vendrell; Simon Cabello‐Aguilar; Sarah Cavaillon; Quentin Dominique Thomas; Jérôme Solassol
作者单位1. Laboratoire de Biologie des Tumeurs Solides, CHU Montpellier Université de Montpellier Montpellier France; 2. MOBIDIC Montpellier France; 3. Institut du Cancer de Montpellier (ICM) Montpellier France; 4. Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm Université de Montpellier, Institut Régional du Cancer de Montpellier (ICM) Montpellier France
75
天
46
天
127
天
EGFR Mutations and Recurrence Outcomes in Resected Non‐Small Cell Lung Cancer: An Updated 2015–2025 Systematic Review and Meta‐Analysis
作者Soo Han Kim; Hayoung Seong; Hyojin Jang; Saerom Kim; Wanho Yoo; Jeongha Mok; Kwangha Lee; Ki Uk Kim; Min Ki Lee; Mi‐Hyun Kim; Jung Seop Eom
作者单位1. Department of Internal Medicine Pusan National University School of Medicine Busan Republic of Korea; 2. Department of Internal Medicine Pusan National University Hospital Busan Republic of Korea; 3. Biomedical Research Institute, Pusan National University Hospital Busan Republic of Korea
76
天
The Predictive Value of Neutrophil‐To‐Lymphocyte Ratio ( NLR ) for Response to Neoadjuvant Immunochemotherapy in Resectable IIA – IIIB Non‐Small Cell Lung Cancer in Real‐World Practice
作者Di Meng; Jiacong Liu; Gaoqi Ye; Linhai Zhu; Xuhua Huang; Xiayi Lv; Jian Hu
作者单位1. Department of Thoracic Surgery, the First Affiliated Hospital Zhejiang University School of Medicine Hangzhou China; 2. Key Laboratory of Clinical Evaluation Technology for Medical Device of Zhejiang Province Hangzhou China
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿96.4 天
中位数77 天